臺灣結核病實作指引, published by 衛福部疾病管制署. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/omnifhir/tb/ and changes regularly. See the Directory of published versions
{
"resourceType" : "Procedure",
"id" : "pro-drug-2",
"meta" : {
"profile" : [
🔗 "https://tb.cdc.gov.tw/tb/StructureDefinition/Procedure-tb-drug"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: 操作项目 pro-drug-2</b></p><a name=\"pro-drug-2\"> </a><a name=\"hcpro-drug-2\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-Procedure-tb-drug.html\">特定治療項目-Procedure TB Drug</a></p></div><p><b>status</b>: Completed</p><p><b>code</b>: <span title=\"Codes:\">A2</span></p><p><b>subject</b>: <a href=\"Patient-pat-min.html\">Anonymous Patient Male, DoB: 1986-01-01 ( National Person Identifier where the xxx is the ISO table 3166 3-character (alphabetic) country code: M123456789\u00a0(use:\u00a0official))</a></p></div>"
},
"status" : "completed",
"code" : {
"text" : "A2"
},
"subject" : {
🔗 "reference" : "Patient/pat-min"
}
}